Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model

Dolk, Christiaan; Eichner, Martin; Welte, Robert; Anastassopoulou, Anastassia; Van Bellinghen, Laure-Anne; Nautrup, Barbara Poulsen; Van Vlaenderen, Ilse; Schmidt-Ott, Ruprecht; Schwehm, Markus; Postma, Maarten

dc.contributor.author	Eichner, Martin
dc.date.accessioned	2018-09-17T08:25:57Z
dc.date.available	2018-09-17T08:25:57Z
dc.date.issued	2016
dc.identifier.issn	1179-2027
dc.identifier.uri	http://hdl.handle.net/10900/84195
dc.language.iso	en	de_DE
dc.publisher	Adis Int Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s40273-016-0443-7	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	300	de_DE
dc.subject.ddc	330	de_DE
dc.subject.ddc	610	de_DE
dc.title	Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model	de_DE
dc.type	Article	de_DE
utue.quellen.id	20180405102126_00266
utue.publikation.seiten	1299-1308	de_DE
utue.personen.roh	Dolk, Christiaan
utue.personen.roh	Eichner, Martin
utue.personen.roh	Welte, Robert
utue.personen.roh	Anastassopoulou, Anastassia
utue.personen.roh	Van Bellinghen, Laure-Anne
utue.personen.roh	Nautrup, Barbara Poulsen
utue.personen.roh	Van Vlaenderen, Ilse
utue.personen.roh	Schmidt-Ott, Ruprecht
utue.personen.roh	Schwehm, Markus
utue.personen.roh	Postma, Maarten
dcterms.isPartOf.ZSTitelID	Pharmacoeconomics	de_DE
dcterms.isPartOf.ZS-Issue	12	de_DE
dcterms.isPartOf.ZS-Volume	34	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE